research Evaluation of Ivermectin for Treatment of Hair Loss Syndrome in Black-Tailed Deer
Ivermectin effectively treats hair loss syndrome in black-tailed deer.
Search
for
Sort by
Research
30 / 1000+ resultsresearch CFTR Potentiator Ivacaftor Protects Against Noise-Induced Hair Cell Loss by Increasing Nrf2 and Reducing Oxidative Stress
Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.
research Hydroxychloroquine, Nitazoxanide, and Ivermectin Have Similar Effects in Early COVID-19: A Head-to-Head Comparison of the Pre-AndroCoV Trial
Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.
research Overnight Loss of Pigmented Hair in Autoimmune Autonomic Neuropathy Treated with IVIg
IVIg treatment improved symptoms but caused permanent dark hair loss.
research The Effects of Hair Regrowth with Intravenous Immunoglobulin (IVIG) Therapy: Two Case Reports
IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.
research IV International Symposium of Student Scientific Circles: Environment - Plant - Animal - Product Abstracts
Custom skincare can be made based on genes, fewer cats in Lublin have FeLV/FIV than national average, and studies also looked at small water bodies, river pollution, guppy growth, toxins in biochars, palm oil issues, and pumpkin seed oil for hair strength.
research A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia
IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.
research A Microfluidic Application for Mass Production of Drug-Loaded Polymeric Microspheres for a Long-Acting Injectable With IVL-DrugFluidic, a Novel Microfluidic Microsphere Manufacturing Platform Technology
IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.
research Novel Effects of Ivermectin in Rosacea: Reduction of Erythema, Flushing, Skin Texture, and Invisible Symptoms
Ivermectin 1% cream effectively reduces visible and invisible symptoms of rosacea.
research The Influence of Non-Esterified Fatty Acids on Ovarian Androgen Production in IVF – Preliminary Results
High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.
research Oral Ivermectin in the Treatment of Scabies
Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.
research Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/FasL-Mediated Apoptotic Signaling
Astragaloside IV may help prevent hair loss by blocking a specific pathway that leads to cell death.
research Enrichment and Characterization of Human Dermal Stem/Progenitor Cells Using Collagen Type IV
Scientists identified a group of human skin cells with high growth and regeneration potential.
research Long Pulsed Nd: YAG Laser with Inbuilt Cool Sapphire Tip for Long-Term Hair Reduction on Type IV and V Skin: A Prospective Analysis of 200 Patients
Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.
research Alexandrite Laser Hair Removal Is Safe For Fitzpatrick Skin Types IV-VI
Alexandrite laser hair removal is safe for darker skin tones.
research The Reduction of Selenium(IV) by Boreal Pseudomonas sp. Strain T5-6-I – Effects on Selenium(IV) Uptake in Brassica oleracea
Pseudomonas sp. T5-6-I bacteria increase selenium uptake in Brassica oleracea plants by 130%.
research Hair Removal With the 3-Msec Alexandrite Laser in Patients With Skin Types IV-VI: Efficacy, Safety, and the Role of Topical Corticosteroids in Preventing Side Effects
The laser effectively removes hair for skin types IV and V but is less effective for type VI.
research Bilateral Temporal Triangular Alopecia Associated with Phakomatosis Pigmentovascularis Type IV Successfully Treated with Follicular Unit Transplantation
Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.
research Laser Hair Removal in Fitzpatrick Type IV to VI Patients
Laser hair removal can be safe and effective for dark-skinned individuals with the right laser settings.
research Treatment of Trichostasis Spinulosa in Skin Phototypes III, IV, and V With an 800-nm Pulsed Diode Laser
The 800-nm pulsed diode laser is a safe and effective long-term treatment for trichostasis spinulosa in dark-skinned individuals.
research Urticariform Plaques: Delayed Hypersensitivity Reaction Type IV to Enoxaparin
A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.
research A Clinical Study of Androgenetic Alopecia IV
research Alopecia in Children and Adults with Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor
research Design of an Artificial Skin. IV. Use of Island Graft to Isolate Organ Regeneration from Scar Synthesis and Other Processes Leading to Skin Wound Closure
Island grafts can help study skin regeneration separately from other healing processes.
research Forensic Chemical Study on Human Hair: Identification of Hair Spray and Hair Growth Promoter Brands by Components Remaining on Human Hair
Chemical analysis of hair products on human hair can help identify specific brands and link suspects to victims.
research Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)
Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.
research Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial)
Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.
research Evaluation of the Safety and Effectiveness of Intradermal Administration of QR678 Neo Hair Growth Factor Formulation: A Phase-IV, Open-Label, Single-Arm Multi-Ethnicity Clinical Trial
QR678 Neo® is a safe and effective treatment for hair loss in men and women.
research The Efficacy and Safety of 17α-Estradiol (Ell-Cranell Alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.